Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores (Posted May 26, 2024 11AM)

https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=diabetes&query=home From the abstract: "Identifying biomarkers of functional ß-cell loss is an important step in the risk stratification of type 1 diabetes. Genetic risk scores (GRS), generated by profiling an array of single nucleotide polymorphisms, are a widely used type 1 diabetes risk-prediction tool. Type 1 diabetes screening studies have relied on a combination of biochemical (autoantibody) and GRS screening methodologies for identifying individuals at high-risk of type 1 diabetes. "